Cargando…
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity with type 2 diabetes. The existing therapeutic options for NAFLD are not adequate. Hypocaloric diet and exercise is the cornerstone of therapy in NAFLD. Pioglitazone is the only drug recommended in diabetes patients with b...
Autores principales: | Raj, Henith, Durgia, Harsh, Palui, Rajan, Kamalanathan, Sadishkumar, Selvarajan, Sandhiya, Kar, Sitanshu Sekhar, Sahoo, Jayaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379733/ https://www.ncbi.nlm.nih.gov/pubmed/30788048 http://dx.doi.org/10.4239/wjd.v10.i2.114 |
Ejemplares similares
-
Role of bisphosphonates in the management of acute Charcot foot
por: Durgia, Harsh, et al.
Publicado: (2018) -
Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial
por: Durgia, Harsh, et al.
Publicado: (2021) -
The Risk of Fractures in Primary Hyperparathyroidism: A Meta‐Analysis
por: Narayanan, Niya, et al.
Publicado: (2021) -
Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis
por: Palui, Rajan, et al.
Publicado: (2020) -
Timing of osteoporosis therapies following fracture: the current
status
por: Palui, Rajan, et al.
Publicado: (2022)